Stoke Therapeutics (STOK) Payables (2022 - 2025)
Historic Payables for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $5.9 million.
- Stoke Therapeutics' Payables rose 13625.75% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 13625.75%. This contributed to the annual value of $2.5 million for FY2024, which is 4737.46% up from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Payables is $5.9 million, which was up 13625.75% from $4.3 million recorded in Q2 2025.
- Stoke Therapeutics' 5-year Payables high stood at $5.9 million for Q3 2025, and its period low was $766000.0 during Q4 2022.
- Its 4-year average for Payables is $2.9 million, with a median of $2.5 million in 2024.
- As far as peak fluctuations go, Stoke Therapeutics' Payables crashed by 5680.18% in 2023, and later skyrocketed by 15353.47% in 2024.
- Stoke Therapeutics' Payables (Quarter) stood at $766000.0 in 2022, then surged by 121.28% to $1.7 million in 2023, then surged by 47.37% to $2.5 million in 2024, then skyrocketed by 135.03% to $5.9 million in 2025.
- Its Payables stands at $5.9 million for Q3 2025, versus $4.3 million for Q2 2025 and $2.2 million for Q1 2025.